Building Trust in Government Podcast: Episode 8

Episode 8: Bio preparedness: Responding to Future Biological Threats

The COVID pandemic caught the U.S. and the world off guard in 2020. Nearly three years later, are we building and sustaining capabilities to continue to respond to the dynamic COVID-19 threat? Are we effectively preparing for the next biological threat? Do we have actionable, funded plans for developing, testing, and manufacturing treatments and vaccines? And do we have the partnerships and supply chains to deploy them? Hear from Dr. Julie Gerberding of the Foundation for the National Institutes of Health; Dr. Matthew Hepburn, who leads pandemic preparedness for the White House Office of Science and Technology Policy; and Dr. Monique K. Mansoura of MITRE.

Hepburn leads a White House team that recently published a progress report on pandemic preparedness. Mansoura co-led a team with Dr. Jay Schnitzer; MITRE Senior Vice President, Chief Technology Officer, and Chief Medical Officer; that developed a 10-point action plan on sustaining a biopharma industrial base to enhance our health, economic and national security.